Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:24 AM
Ignite Modification Date:
2025-12-25 @ 3:24 AM
NCT ID:
NCT00292305
Eligibility Criteria:
Inclusion Criteria:
* Stable or unstable AP.
* Bifurcation lesion of "LAD/diagonal", "Cx/obtuse marginal", "RCA-PDA/posterolateral branch" or "LM/Cx/LAD".
* Diameter of main vessel by visual estimate \> 3.0 mm.
* Diameter of side branch by visual estimate \> 2.5 mm.
* Signed informed consent
Exclusion Criteria:
* ST-elevation AMI within 24 hours.
* Expected survival \< 1 year.
* S-creatinine \> 200 Umol/l.
* Allergy to aspirin, clopidogrel or ticlopidine.
* Allergy to sirolimus.
* Left main bifurcation in a non-right dominant system.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT00292305
Study Brief:
Protocol Section:
NCT00292305